{
    "title": "113_hr5790",
    "content": "The Act titled \"Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014\" introduces prize competitions for improving health outcomes and reducing federal expenditures under the Public Health Service Act. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 aims to improve health outcomes and reduce Federal expenditures on health programs through prize competitions. The Director of NIH will identify 3 to 5 human diseases or health conditions in consultation with relevant experts. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 requires the Federal Government to spend at least $5 billion per year on prevention and treatment activities for specified diseases. Additionally, it highlights the need for increased research investment in these diseases compared to others with similar funding levels. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 mandates the NIH Director to design prize competitions within 12 months to achieve specified goals. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 requires the NIH Director to create prize competitions for innovative solutions to identified diseases or conditions. Prizes may be awarded at the beginning or end of the competitions to promising competitors. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 mandates NIH Director to organize prize competitions for innovative solutions to diseases. Competitions should be realistic, unbiased, and open to all participants. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 requires the NIH Director to organize unbiased prize competitions for innovative solutions to diseases, addressing areas of unmet need. The Director must consult with various experts in medical, economic, budgetary, and innovation fields. The Health Prizes Rewarding Innovation, Savings, and Effectiveness Act of 2014 mandates the NIH Director to conduct unbiased prize competitions for innovative disease solutions. The Director must consult with medical, economic, budgetary, and innovation experts, as well as heads of relevant Federal agencies. The Director of NIH is required to award contracts for a simulation of the prize within 14 months of the Act's enactment. The NIH Director is mandated to conduct prize competitions for innovative disease solutions. The Director must consult with experts and agency heads, award contracts for a simulation of the prize, and submit a report to Congress on the results within 4 months. Adjustments to the design must be made within 21 months. The Director of NIH must make adjustments to the design of prize competitions within 21 months and submit a report to Congress. The Director of NIH will implement prize competitions with private entities based on designs developed under subsection (b)(2), lasting up to 5 years to demonstrate innovation effectiveness. The Secretary and the Commissioner of Food and Drugs may provide guidance and testing facilities to competitors. The Director of NIH will conduct up to 5 prize competitions, with a limit of 2 competitions per disease or condition. The Director will track and report on the medical efficacy of funded innovations and their impact. The Director of NIH will conduct prize competitions, tracking the impact of innovations on Federal expenditures. A report will be submitted to Congress annually for 4 years. The government is prohibited from acquiring intellectual property rights without written consent. The Federal Government may negotiate licenses for intellectual property developed in prize competitions. $50,000,000 is authorized for appropriations to carry out this section. Under subsection (e), assistance awarded to private entities for prize competitions must allocate no more than 30% for administration and at least 70% as prizes to competitors. This excludes prizes from being included in the gross income of recipients under the Internal Revenue Code. The amendment to Section 74 of the Internal Revenue Code excludes the value of prizes received from prize competitions under section 409K of the Public Health Service Act from gross income. This amendment applies to taxable years ending after the enactment of the Act."
}